|
MRPL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.47620000000715E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.248600E-04 |
| Normal-vs-Stage2 |
3.236400E-02 |
| Normal-vs-Stage3 |
4.978700E-04 |
| Normal-vs-Stage4 |
1.319500000041E-06 |
| Stage1-vs-Stage2 |
4.954800E-01 |
| Stage1-vs-Stage3 |
4.949800E-01 |
| Stage1-vs-Stage4 |
1.951870E-02 |
| Stage2-vs-Stage3 |
2.825600E-01 |
| Stage2-vs-Stage4 |
1.077980E-02 |
| Stage3-vs-Stage4 |
9.830300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.83469999999586E-05 |
| Normal-vs-AfricanAmerican |
1.2858000000282E-06 |
| Normal-vs-Asian |
2.593600E-02 |
| Caucasian-vs-AfricanAmerican |
2.473900E-02 |
| Caucasian-vs-Asian |
1.232610E-01 |
| AfricanAmerican-vs-Asian |
5.597400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.194460E-04 |
| Normal-vs-Female |
2.414600E-04 |
| Male-vs-Female |
3.579800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.016700E-04 |
| Normal-vs-Age(41-60Yrs) |
3.401700E-04 |
| Normal-vs-Age(61-80Yrs) |
5.605900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.746000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.127800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.582800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.809600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.934600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.651200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.616200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.900600E-01 |
| Classical-VS-Follicular |
9.587000E-01 |
| Classical-VS-Other |
3.532400E-01 |
| Classical-VS-Normal |
2.379200E-04 |
| Tall-VS-Follicular |
9.673600E-01 |
| Tall-VS-Other |
4.058600E-01 |
| Tall-VS-Normal |
1.320230E-02 |
| Follicular-VS-Other |
4.332200E-01 |
| Follicular-VS-Normal |
5.316300E-03 |
| Other-VS-Normal |
3.512500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.084240E-03 |
| Normal-vs-N1 |
2.21219999985145E-07 |
| N0-vs-N1 |
2.876100E-03 |
|
|
